"The Janssen Prevention Center was established by the Janssen Pharmaceutical Companies of Johnson & Johnson to drive ground-breaking research into disease prevention in major areas of unmet medical need."
"The research focuses on the prevention of chronic diseases often related to aging and lifestyle. These include Alzheimer’s disease, cardiovascular disease, cancer and autoimmune diseases. New approaches to disease prevention are needed to stop the emerging epidemics of age-related chronic diseases.
Over the past 100 years, preventive strategies like childhood vaccination have proven very successful for controlling epidemics of many infectious diseases. The possibility of preventing age-related chronic illnesses is seen as the new prevention frontier. Possible preventive medicine solutions could include vaccines, drugs and interventions that influence the composition of the human microbiome.
Launched at the start of 2015, the Janssen Prevention Center currently employs around 120 scientists and support staff. They are based in the Netherlands (Leiden), the United States (La Jolla, California) and the United Kingdom (London). The center has its global headquarters in Leiden and laboratories in all three locations."